← FDA Drug Approvals (Drugs@FDA)
CYTARABINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2022-02-28
Drug application
- FDA Application #
ANDA208485- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CYTARABINE
- Generic name
- CYTARABINE
- Active ingredients
- CYTARABINE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- MEITHEAL
- Manufacturer
- Meitheal Pharmaceuticals Inc.
- First approval
- 2022-02-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown